Company intelligence / Profile preview

Olive

Columbus, Ohio, USA

Ownership: Private
Development stage: Other

Overview

Olive developed AI-powered automation solutions for healthcare operations such as prior authorization, claims processing, analytics, and supply chain optimization; it achieved broad deployment (900+ hospitals) but shut down operations and sold off core assets in 2023-2024 due to financial difficulties.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Waystar (acquirer of clearinghouse and patient access businesses)Humata Health (acquirer of prior authorization business unit)Availity (acquirer of utilization management solution)Empiric Health (acquired by Olive in 2021)Asus (collaboration for AI coding assistant)

Beyond the preview

Go deeper on Olive.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olive.

Explore the full profile